Global Biopsy Guidance System Market by Product (MRI Guided Biopsy, Stereotactic Guided Biopsy, Ultrasound Guided Biopsy), Application (Brain Biopsy, Breast Biopsy, Lungs), End-Use - Forecast 2024-2030

Report
182 Pages
June 2024
Region: Global
360iResearch™
ID: 5454872

The Biopsy Guidance System Market grew from USD 1.44 billion in 2023 to USD 1.54 billion in 2024. It is expected to continue growing at a CAGR of 7.34%, reaching USD 2.38 billion by 2030.

These biopsy guidance systems utilize a variety of modalities such as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), and other image-guided technologies to provide real-time assistance in accurately locating and targeting abnormal tissue for a biopsy. The growing incidences of cancer and gastrointestinal diseases is increasing the need for biopsy guidance systems. The rising awareness of breast cancer treatment & diagnosis and increasing preference for minimally invasive biopsy treatments has significantly contributing to the market growth. However, high cost associated with the production of biopsy guidance systems may limit the adoption of biopsy guidance systems. Technical complexities associated with biopsy guidance systems are also a concerning factor for the market growth. Moreover, the technological advancements in biopsy guidance systems is expected to create significant growth potential in the market. Improved healthcare infrastructure and healthcare spending are also anticipated to generate attractive opportunities for the market growth.

Regional Insights

The Americas region is characterized by the presence of advanced healthcare infrastructure, higher healthcare spending, and a greater emphasis on early diagnosis and personalized medicine, which fuels the need for sophisticated biopsy guidance systems. Additionally, this region remains a hub for innovative startups and established companies seeking to improve the performance of cancer diagnostics. The European Union is associated with the widespread adoption of biopsy guidance systems due to the region's strong healthcare policies and well-established reimbursement frameworks. There is an emphasis on quality healthcare with a focus on advanced medical devices. The EU's regulatory environment also supports innovation through funding initiatives and facilitates research collaborations between private and public players. Asia Pacific is a rapidly growing region in the biopsy guidance system market. In China, large-scale investments in healthcare and growing public awareness about cancer are key factors propelling the need for biopsy guidance systems. The Chinese government's initiatives to reform healthcare and emphasis on emerging medical technologies have driven the adoption of advanced biopsy systems. Technological innovation, high healthcare standards, and a rapidly aging population drive Japan's need for biopsy guidance systems.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Biopsy Guidance System Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Growing incidences of cancer and chronic diseases requiring diagnostic procedures
Increasing preference for minimally invasive biopsy treatments
Government campaigns and initiatives for early disease diagnosis

Market Restraints

Need for specialized training and inaccuracy of biopsy systems

Market Opportunities

Technological advancements in biopsy guidance systems
Favorable reimbursement policies for biopsy procedures

Market Challenges

Technical complexities associated with biopsy guidance system

Market Segmentation Analysis

Product: Increasing inclination towards ultrasound guided biopsy for improved imaging capabilities
Application: Improved applications for breast biopsies for enhanced accuracy
End-Use: Adoption of biopsy guidance systems in hospitals to enable high-quality imaging for diagnostic applications

Industry Insights

Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biopsy Guidance System Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biopsy Guidance System Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

FDA Clears MRI-Compatible Robotics System for Breast Biopsy

Insight Medbotics received United States Food and Drugs Administration (FDA) 510(k) clearance of its innovative IGAR (Image-Guided Autonomous Robot) system, marking it as the inaugural robotic platform sanctioned for deployment within an MRI bore, specifically tailored for breast biopsy procedures. This breakthrough underscores Insight Medbotics' commitment to being a key player in patient-centric innovations in medical imaging and biopsy techniques.

Stryker Launches Q Guidance with Cranial Guidance Software

Stryker Corporation announced the launch of its innovative Q Guidance System, enhanced with cranial guidance software. This state-of-the-art system represents the forefront of surgical planning and operative precision in cranial procedures. The Q Guidance System is ingeniously designed to facilitate intricate tasks such as superlative instrument positioning and critical patient anatomy recognition during neural operations. This strategic move by Stryker closely follows the recent unveiling of the Ortho Q fully autonomous guidance system, marking another significant milestone in Stryker's commitment to innovative medical technology.

GE HealthCare Announces Agreement to Acquire IMACTIS to Strengthen Capabilities in Interventional Guidance

GE Healthcare announced the acquisition of IMACTIS, a key player in the dynamic domain of CT interventional guidance, committed to enhancing various medical care procedures. IMACTIS is a France-based company that created CT-Navigation. This ergonomic universal solution provides stereotactic needle guidance and enables intuitive pre-planning of various procedures, from diagnosis to treatment. GE HealthCare is set to leverage its vast market presence to augment the reach and impact of IMACTIS's cutting-edge CT navigation, thereby elevating the precision and efficiency of healthcare services provided to its widespread client base.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biopsy Guidance System Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biopsy Guidance System Market, highlighting leading vendors and their innovative profiles. These include Argon Medical Devices, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biobot Surgical Pte Ltd., Body Vision Medical Ltd., Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Danaher Corporation, Fujifilm Holdings Corporation, GE Healthcare, Hologic, Inc., IMS Giotto S.p.A, Inomed Health Limited, INRAD Inc., IZI Medical Products, KOELIS, Koninklijke Philips N.V., KPI Healthcare India pvt Ltd, Mauna Kea Technologies, Medtronic PLC, Merit Medical Systems, NeoDynamics AB, Olympus Corporation, Planmed Oy, Siemens Healthineers AG, STERYLAB S.r.l., Stryker Corporation, and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Biopsy Guidance System Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

MRI Guided Biopsy
Stereotactic Guided Biopsy
Ultrasound Guided Biopsy

Application

Brain Biopsy
Breast Biopsy
Lungs
Prostate

End-Use

Diagnostic Centers
Hospitals
Research & Academic Institutes
Specialty Clinics

Region

Americas

Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific

Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa

Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Additional Product Information:

The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
Purchase of this report includes 1 year online access with quarterly updates
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidences of cancer and chronic diseases requiring diagnostic procedures
5.1.1.2. Increasing preference for minimally invasive biopsy treatments
5.1.1.3. Government campaigns and initiatives for early disease diagnosis
5.1.2. Restraints
5.1.2.1. Need for specialized training and inaccuracy of biopsy systems
5.1.3. Opportunities
5.1.3.1. Technological advancements in biopsy guidance systems
5.1.3.2. Favorable reimbursement policies for biopsy procedures
5.1.4. Challenges
5.1.4.1. Technical complexities associated with biopsy guidance system
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing inclination towards ultrasound guided biopsy for improved imaging capabilities
5.2.2. Application: Improved applications for breast biopsies for enhanced accuracy
5.2.3. End-Use: Adoption of biopsy guidance systems in hospitals to enable high-quality imaging for diagnostic applications
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Biopsy Guidance System Market, by Product

6.1. Introduction
6.2. MRI Guided Biopsy
6.3. Stereotactic Guided Biopsy
6.4. Ultrasound Guided Biopsy

7. Biopsy Guidance System Market, by Application

7.1. Introduction
7.2. Brain Biopsy
7.3. Breast Biopsy
7.4. Lungs
7.5. Prostate

8. Biopsy Guidance System Market, by End-Use

8.1. Introduction
8.2. Diagnostic Centers
8.3. Hospitals
8.4. Research & Academic Institutes
8.5. Specialty Clinics

9. Americas Biopsy Guidance System Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Biopsy Guidance System Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Biopsy Guidance System Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. FDA Clears MRI-Compatible Robotics System for Breast Biopsy
12.3.2. Stryker Launches Q Guidance with Cranial Guidance Software
12.3.3. GE HealthCare Announces Agreement to Acquire IMACTIS to Strengthen Capabilities in Interventional Guidance
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio

List of Figures

FIGURE 1. BIOPSY GUIDANCE SYSTEM MARKET RESEARCH PROCESS
FIGURE 2. BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOPSY GUIDANCE SYSTEM MARKET DYNAMICS
FIGURE 7. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BIOPSY GUIDANCE SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. BIOPSY GUIDANCE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. BIOPSY GUIDANCE SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MRI GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MRI GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STEREOTACTIC GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STEREOTACTIC GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BRAIN BIOPSY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BRAIN BIOPSY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY LUNGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY LUNGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PROSTATE, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PROSTATE, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 51. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 52. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 55. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 56. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 57. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 58. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 59. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 60. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 61. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 62. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 63. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 64. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 65. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 66. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 72. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 80. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 82. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 83. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 84. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 85. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 88. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 89. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 90. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 91. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 92. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 93. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 94. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 95. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 98. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 99. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 100. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 101. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 102. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 103. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 106. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 107. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 110. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 111. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 112. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 113. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 114. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 115. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 118. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 119. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 122. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 123. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 124. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 125. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 126. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 127. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 130. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 131. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 134. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 135. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 136. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 137. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 138. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 139. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 142. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 143. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 148. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 149. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 150. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 151. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 154. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 163. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 164. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 165. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 166. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 167. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 168. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 169. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 170. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 171. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 174. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 175. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 176. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 177. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 178. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 179. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 180. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 181. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 186. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 187. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 188. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 189. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 190. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 191. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 192. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 193. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 198. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 199. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 200. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 201. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 202. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 203. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 204. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 205. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 210. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 211. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 214. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 215. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 216. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 217. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 222. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 223. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 224. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 225. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 226. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 227. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 228. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 229. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 230. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 231. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 232. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 233. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 234. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 235. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 236. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 237. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 240. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 246. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 248. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 250. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 252. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 253. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 256. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 257. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 258. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 259. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 260. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 261. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 262. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 263. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 264. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 265. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 270. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 271. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 272. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 273. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 274. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 275. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 276. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 284. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 286. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 288. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 289. BIOPSY GUIDANCE SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
TABLE 290. BIOPSY GUIDANCE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

Argon Medical Devices, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Biobot Surgical Pte Ltd.
Body Vision Medical Ltd.
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Group Incorporated
Danaher Corporation
Fujifilm Holdings Corporation
GE Healthcare
Hologic, Inc.
IMS Giotto S.p.A
Inomed Health Limited
INRAD Inc.
IZI Medical Products
KOELIS
Koninklijke Philips N.V.
KPI Healthcare India pvt Ltd
Mauna Kea Technologies
Medtronic PLC
Merit Medical Systems
NeoDynamics AB
Olympus Corporation
Planmed Oy
Siemens Healthineers AG
STERYLAB S.r.l.
Stryker Corporation
Trivitron Healthcare

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	182
Published	June 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.54 Billion
Forecasted Market Value ( USD ) by 2030	$ 2.38 Billion
Compound Annual Growth Rate	7.3%
Regions Covered	Global
No. of Companies Mentioned	29

PURCHASE OPTIONS

Single User License PDF, Excel And Online Access

1 - 5 User License PDF, Excel And Online Access

Enterprise License PDF, Excel And Online Access

need a quote ?

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3759EUR$3,939USD£3,163GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€4722EUR$4,949USD£3,974GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6650EUR$6,969USD£5,596GBP